Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01252797
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ID5 | [5-FLUORO-2-({[(4,5,7-TRIFLUORO- 1,3-BENZOTHIAZOL-2-YL)METHYL]AMINO}CARBONYL)PHENOXY]ACETIC ACID | A | 1T40 | 0.76 |  |
| ID5 | [5-FLUORO-2-({[(4,5,7-TRIFLUORO- 1,3-BENZOTHIAZOL-2-YL)METHYL]AMINO}CARBONYL)PHENOXY]ACETIC ACID | A | 1T41 | 0.76 | |
MZ5 | (2S)-N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-2-HYDROXY- 3-METHYLBUTANAMIDE | A,B | 2QI3 | 0.77 | |
MZ8 | N-{(1S,2R)-3-[(1,3-BENZOTHIAZOL- 6-YLSULFONYL)(ISOBUTYL)AMINO]-1- BENZYL-2-HYDROXYPROPYL}-3-HYDROXYBENZAMIDE | A,B | 2QI6 | 0.77 | |
C80 | (2S,4S,5R,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL 1- BENZYL-1H-INDOLE-3-CARBOXYLATE | C,O | 2V11 | 0.72 | |
MZ6 | N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-3-HYDROXYBENZAMIDE | A,B | 2QI4 | 0.77 | |
MZ7 | N~2~-ACETYL-N-{(1S,2R)-3-[(1,3- BENZOTHIAZOL-6-YLSULFONYL)(PENTYL)AMINO]- 1-BENZYL-2-HYDROXYPROPYL}-L-VALINAMIDE | A,B | 2QI5 | 0.74 | |
LS3 | 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2- BENZOTHIEN-5-YL)AMINO]METHYLENE}- 5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO- 2H-INDOL-2-ONE | A | 1KE7 | 0.7 | |
AR2 | ARGINYL-BENZOTHIAZOLE-6-CARBOXYLIC ACID | A,B,I | 1DOJ | 0.79 | |
CBB | 1-(3-CARBAMIMIDOYL-BENZYL)-1H-INDOLE- 2-CARBOXYLIC ACID 3-CARBAMIMIDOYL- BENZYLESTER | B | 1LPK | 0.73 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDI | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDX | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DUX | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 1MAR | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DV0 | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDM | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDB | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PD5 | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2FZ9 | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DUZ | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDF | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HVO | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HVN | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2FZ8 | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HV5 | 0.7 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 1FRB | 0.7 | |
735 | 2-METHYL-2-(4-{[({4-METHYL-2-[4- (TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL- 5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID | A | 2P54 | 0.71 | |
P41 | 6-[4-(2-fluorophenyl)-1,3-oxazol- 5-yl]-N-(1-methylethyl)-1,3-benzothiazol- 2-amine | A | 3C5U | 0.77 | |